TrialCNS drugs2023

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects.

Qi Shen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.